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Oxidative stress plays a major part in the pathogenesis of drug-induced liver injury. Yet, overcoming it
with other xenobiotics impose additional risks. In this study, we consider the use of natural-occurring
and puriﬁed Vitamin E analogs as hepatoprotective agents. Vitamin E is well-known for its intrinsic
antioxidant property even though the differential effect of speciﬁc analogs of tocopherol (TP) and to-
cotrienol (T3) is still not ascertained. This study investigates the protective effect of T3 analogs (α-, δ-,
γ) in comparison with α-TP followed by assessing the underlying mechanisms of the cytoprotective T3
analog(s) in two xenobiotics-induced liver injury models using (1) acetaminophen (APAP)- and (2) hy-
drogen peroxide (H2O2). Both α-TP and α-T3 exerted cytoprotective effects while only lower con-
centration of γ-T3 was effective in inhibiting both toxicants induced injury. α-TP/α-T3 protected hepa-
tocytes from APAP and H2O2-induced liver injury through arresting free radicals and inhibiting oxidative
stress (inhibition of reactive oxygen species, lipid peroxidation and mitochondrial permeability transi-
tion). There was also demonstrable inhibition of the apoptotic pathway (inhibition of caspse-3 activity
and overexpression of Bcl-XL), accompanied with an induction of liver regeneration (PCNA and NF-kB).
The cellular uptake of α-T3 was higher than α-TP at the same treatment dosage after 24 h. Overall, α-T3
seems to be a more potent hepatoprotective analog among the tocotrienols and α-TP at the same in vitro
treatment dosage. In summary, these results suggest that α-TP/α-T3 elicit hepatoprotective effects
against toxicants-induced damage mainly through activation of antioxidant responses at an early stage to
prevent the exacerbation of injury.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).B.V. This is an open access article u
ienol; T3, tocotrienol; TP, to-
minophen; H2O2, hydrogen
SF, phenylmethanesulfonyl
nyltetrazolium bromide;
's F12; ITS, insulin, transfer-
ate buffered saline; BSA, bo-
-polymerase chain reaction;
(IL-6); iNOS, inducible nitric
e; HPLC, high performance
factor alpha; PMC, 2,2,5,7,8-
DAD, diode array detector;
; GST, glutathione-s-trans-
idation; MPT, membrane
-related factor; HO-1, Heme
andard error of means
Singapore 117543, Singapore.
),
.com (C.W. Fong),Introduction
Liver plays a central role in the metabolism of xenobiotics
(drugs). As the primary site of Phase I and II enzyme activities,
some drugs can be transformed into hepatotoxic drug metabolites
due to the “ﬁrst pass effect” through the liver. Therefore, liver is
the organ most susceptible to drug-induced injury. Today, drug-
induced liver injury (DILI) accounts for more than 50% of acute
liver failure in the United States and has become a major clinical
problem [1]. Acetaminophen (APAP, also known as paracetamol) is
the drug most often implicated in DILI [2]. Most DILI involves
oxidative stress as a part of the mechanism of cellular injury.
Majority of these oxidative stress events can arise from the gen-
eration of reactive intermediates from drug metabolism [3], de-
pletion of antioxidants [4], increased redox recycling of drugs [5]
and interference of mitochondrial respiration by reactive meta-
bolites [6]. This central role of oxidative stress in DILI presents the
opportunity for natural antioxidants to quench and scavenge free
radicals to prevent the deleterious effects of the toxicants. Thisnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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which may themselves, elicit untoward side health effects.
Vitamin E is well-known for its distinctive antioxidant prop-
erties. Being highly lipophilic, it is effective at alleviating oxidative
damage particularly in lipid-rich environment like cellular mem-
branes. Nature-derived Vitamin E is chemically diverse with dis-
tinct isoforms including α, β, γ and δ-tocopherols (TP) and toco-
trienols (T3). T3 analogs are structurally similar to TP and differ
only in having an unsaturated isoprenoid side chain rather than a
saturated phytyl tail [7]. Recently, a growing number of studies
reported that T3 possess numerous vital functions that are either
not observed in TP or more potent than TP [8]. For instance, T3 has
substantial cholesterol-lowering properties [9,10], anticancer and
tumor-suppressing activities, but not TP [11,12]. On the other
hand, α-T3 which demonstrated the most potent neuroprotection
among Vitamin E analogs [13], was also shown to be cardiopro-
tective [14,15] and has the ability to protect against stroke [16].
Importantly, α-T3 was found to possess more potent antioxidant
properties than other T3 analogs [17,18] and α-TP [19,20]. Based
on this information, it is speculated that they may be particularly
important for the protection against oxidative stress arising from
drugs. However, the potential protective effect of individual T3
analogs and their ability to respond to different mechanisms of
liver injury has never been investigated. Therefore, this work set
out to ﬁrst explore the potential cell death inhibitory effect of T3
analogs in comparison with α-TP followed by assessing the un-
derlying mechanisms of the cytoprotective T3 analog(s) using liver
cell culture models of well-deﬁned xenobiotics-induced liver in-
jury models.Materials and methods
Materials and reagents
Dexamethasone, nicotinamide, gentamicin, HEPES, EDTA, gly-
cerin, Triton-X, sodium chloride (NaCl), sodium ﬂuoride, sodium
orthovanadate, phenylmethanesulfonyl ﬂuoride (PMSF), aprotinin,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), acetaminophen (APAP), hydrogen peroxide (H2O2), mono-
chlorobimane (MCB), L-glutathione reduced (GSH) and glu-
tathione-s-transferase (GST) were obtained from Sigma Chemical
(St. Louis, MO). Dulbecco’s modiﬁed Eagle’s medium/Ham’s F12
(DMEM/F12) and Superscript III First-strand Synthesis System
were products of Invitrogen (Carlsbad, CA). Insulin, transferrin,
selenium cocktail (ITS) was from BD (Franklin Lakes, NJ). Di-
methylsulfoxide (DMSO) was obtained from Merck (Darmstadt,
Germany). SYBR Green PCR master mix was obtained from Applied
Biosystems (Warrington, UK). RNeasys mini kit was product of
Qiagen (Hilden, Germany). Phosphate buffered saline (PBS) and all
primers were synthesized by 1st BASE Oligos (Singapore). Primary
antibodies were purchased from the following companies: pro-
liferating cell nuclear antigen (PCNA) and NF-kB p65, Cell Signaling
Technology (Danvers, MA); Bcl-xL (H-5), Nrf-2 (C-20), p-Met (Tyr
1234), Santa Cruz Biotechnology (Dallas, TX); HO-1, Enzo Life
Science (Farmingdale, NY); β-actin, Abcam (Cambridge, UK).
CM-H2DCFDA and JC-1 dye were purchased from Molecular Probe
(Carlsbad, CA); TBARS assay kit was obtained from Cayman Europe
(Tallinn, Estonia) while Caspase-Glos 3/7 Reagent assay kit was
purchased from Promega (Madison, WI).
Preparation and quantiﬁcation of vitamin E derived α-TP and T3
T3 and TP analogs were supplied by Davos Life Science Pte. Ltd.,
Singapore. The appearance of the pure compounds was oily li-
quids. They were dissolved in absolute ethanol (100 mM) andstored at 20 °C. Using the corresponding T3 analogs as the re-
ference standard, the purity of T3 and α-TP analogs was veriﬁed to
be Z97% by HPLC.
Cell lines and culture conditions
Immortalized murine transforming growth factor alpha (TGF-
α) transgenic hepatocyte (TAMH) cells [21], (obtained as a kind gift
from Prof Nelson Fausto, University of Washington, USA), was used
as a metabolically competent liver cell line that reproduced fea-
tures of cytotoxicity to support this investigation. Although
transgenic, this cell line still maintained normal hepatocyte mor-
phology and remained non-tumorigenic even after prolonged
passage and culturing [22]. TAMH cells were maintained in
DMEM/F12 supplemented with 5 mg/ml insulin, 5 mg/ml trans-
ferrin, 5 ng/ml selenium, 100 nM dexamethasone, 10 mM nicoti-
namide and 0.01% (v/v) gentamicin. Cells were maintained at 37 °C
in a humidiﬁed 95% air and 5% CO2 atmosphere, passaged and
when reached 80–90% conﬂuency.
In vitro cell viability assay
Using 96-well plate, TAMH cells were seeded at a density of
6103 cells/well in 200 ml DMEM/F12 medium. Vitamin E analogs
with different concentrations of stock solutions were prepared and
diluted at 1000-fold in the culturing media to the working con-
centration. For the cytotoxicity test, cells were treated with various
concentrations (10–100 mM) of α-TP/T3 analogs with 0.1% ethanol
vehicle for 24 h. Cell viability assays were performed after the
incubation time to determine the cytotoxicity of each analog. In
the concurrent treatment, TAMH cells were treated 2 mM APAP or
450 mM H2O2 concurrently with respective analog for 24 h before
performing the cell viability test. Pre-treatment experiments in-
volved 24 h incubation of the α-TP/T3 analogs. Thereafter, cells
were subjected to a complete rinse with PBS followed by the APAP
or H2O2 incubation for another 24 h. Each of the diluted α-TP/T3
analog mixture in the culturing medium was vortexed for 30 s
before treated into each wells. Control cultures received ethanol
vehicle (0.1%). Following incubation of toxicants with different
concentrations of the α-TP/T3 analogs, the cell viability was eval-
uated by MTT assay. 20 ml of 5 mg/ml MTT was dissolved in PBS.
After the incubation period, the media was aspirated and the
formazan crystals in cells were dissolved in 200 ml of DMSO and
25 ml of Sorenson's buffer [23]. The absorbance was measured at
570 nm using Inﬁnites 200 PRO (Tecan, Switzerland) microtiter
plate reader. Cell viability percentage was expressed as a ratio of
cells exposed to different concentrations of toxicants with those of
vehicle controls.
In vitro cellular uptake of vitamin E analogs (α-TP and T3 analogs)
TAMH cells (4106) were seeded into T-75 ﬂask overnight.
Each ﬂask of cells which contained 15 ml of DMEM/F12 medium
was treated with 5, 10, 25, 50 and 100 mM of each analog for 24 h.
Cells were harvested, washed with PBS twice before each sample
cell pellet was lysed in 400 ml of lysis buffer (1% Triton X-100,
pH 7.5, 20 mM HEPES buffer with 0.1 mM EDTA). 1 ml of 0.01% BHT
(anti-oxidant) ethanol solution and 0.01 mg 2,2,5,7,8-penta-
methyl-6-chromal (PMC) as internal control were added into the
lysates. 3 ml of hexane were then added and the mixtures were
vortexed for 5 min and centrifuged at 4000 rpm for 10 min. The
extraction process was performed twice. The cellular Vitamin E in
the upper hexane layer were extracted, dried, reconstituted in
600 ml hexane and analyzed with Agilent HPLC system using Li-
chrospher Si 60, 2504 mm2, 5 mm cartridge normal phase col-
umn attached to ﬂuorescence detector (FLD) and diode array
Table 1
Sequences of primers used in real time PCR reaction [49].
Gene Forward primer (5′-43′) Reverse primer (5′-43′)
In vitro hepatocytes (TAMH cells)/in vivo liver (mouse)
TNF-α ATG AGC ACA GAA AGC ATG ATC TAC AGG CTT GTA ACT CGA ATT
IL-6 AGT TGC CTT CTT GGG ACT GA TCC ACG ATT TCC CAG AGA AC
iNOS CAC CTT GGA GTT CAC CCA GT ACC ACT CGT ACT TGG GAT GC
C.Y. Tan et al. / Redox Biology 4 (2015) 308–320310detector (DAD) detector. Each α-TP or T3 was obtained by collec-
tion of each peak fraction during HPLC. The amount of α-, γ- and
δ-T3 and α-TP were quantiﬁed against a standard curve estab-
lished from puriﬁed standards.
Reverse transcription and quantitative real time-polymerase chain
reaction (qRT-PCR)
In a 6 well plate, TAMH cells were seeded at a density of
5105 cells/well and treated with 2 mM APAP or 350 mM H2O2
concurrently with 10 or 50 mM of α-TP or α-T3 for 24 h. All cells
were harvested for total cell RNA extraction using RNeasy columns
(Qiagen, Valencia, CA). The quality and quantity of total RNA was
determined with NanoDrop (Thermo, Wilmington, DE), ensuring
that RNAs with OD 260/280 41.80 were used. First-strand cDNA
was synthesized from 1 mg total RNA using Superscript First-Strand
Synthesis System according to the protocols of the manufacturer.
qRT-PCR was performed using BioRad CFX96 real time PCR system
with SYBR Green master mix and primers as shown in Table 1. The
thermal cycling condition comprised an initial denaturation at
95 °C (10 min), followed by 40 cycles at 95 °C (15 s) and 60 °C
(60 s). Melting curves were generated at the end of 40 cycles to
verify the purity of the PCR product. Data were obtained as aver-
age Ct values, and normalized against the geometric mean of
GAPDH endogenous controls as ΔCt. Transcript differences be-
tween α-TP or α-T3 treated group and non-treated group were
measured as fold changes using the comparative Ct method. Sta-
tistics were performed on Ct using REST software (Qiagen, Va-
lencia, CA).
Western blots
TAMH cells were seeded at 2106 in a 10 cm dish with DMEM/
F12 medium overnight. Cells were then treated with respective
concentration of APAP or H2O2 and α-TP/T3 analogs for 24 h. All
cells were harvested for western blot analysis. Cell pellets were
lysed with 100 ml of RIPA lysis buffer containing 50 mM Tris,
150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40,
0.5 M sodium ﬂuoride, 100 mM sodium orthovanadate, 100 mM
PMSF and 20 mg/ml aprotinin. 10 mg/cell sample were resolved in
10% SDS-PAGE and immobilized on PVDF membrane. The mem-
branes were blocked in 5% milk for 1 h and incubated in respective
primary antibodies overnight (NF-κB 1:2000; Bcl-XL 1:1000; PCNA
1:10,000; pMet 1:400; HO-1 1:1000 and Nrf-2 1:2000), followed
by respective secondary antibody (1:10,000) incubation for 1 h. All
membranes were visualized using chemiluminescence substrate
(Pierce Biotechnology, Rockford, IL). The bands intensities were
normalized against actin and were quantiﬁed using ImageJ soft-
ware [24].
Determination of GSH content
2106 TAMH cells were seeded into 6-well plates overnight.
Cells were treated 2 mM APAP or 450 mM H2O2 concurrently with
10 or 50 mM of α-TP or α-T3 for 24 h. Cells were then harvested
and washed with PBS twice. 200 ml of lysis buffer (0.1% Triton-X/1 M Tris/HCl) were added. The cells were sonicated in a sonicating
bath for 5 min and incubated in ice for 15 min before centrifuga-
tion. 10 ml of each supernatant or GSH standard were added into
each well in a 96 well plate in duplicate. 90 ml of the MCB and GST
mixture (ﬁnal concentration 10 nmol of MCB and 0.1 unit of GST)
were added into each well. The plate was incubated at 37 °C for
60 min before it was measured using ﬂuorescent plate reader with
excitation wavelength at 380 nm and emission wavelength at
470 nm.
Determination of intracellular reactive oxygen species (ROS)
2.5104 TAMH cells were seeded into 96-well plates over-
night. 2 mM APAP or 450 mM H2O2 were treated concurrently with
10 or 50 mM of α-TP or α-T3 for 24 h. The cells were then incubated
with 25 mM CM-H2DCFDA for 45 min at 37 °C and washed three
times with PBS. The plate was measured using Inﬁnites 200 PRO
(Tecan, Switzerland) ﬂuorescent plate reader with excitation wa-
velength at 485 nm and emission wavelength at 535 nm. Levels of
intracellular ROS were then normalized against total cell number
of their respective groups.
Determination of intracellular lipid peroxidation (LPO)
4106 TAMH cells were seeded into T-75 ﬂask overnight.
2 mM APAP or 450 mMH2O2 were treated concurrently with 50 mM
α-TP or α-T3 in each ﬂask for 24 h. The cellular MDA level was
determined with a TBARS assay kit performed according to the
manufacturer’s protocol. The MDA levels were measured using
Inﬁnites 200 PRO (Tecan, Switzerland) ﬂuorescent plate reader
with excitation wavelength at 530 nm and emission wavelength at
540 nm.
Determination of membrane potential transition (MPT)
1.5104 TAMH cells/well were seeded in a 96 well plate for
overnight. 2 mM APAP or 450 mM H2O2 were treated concurrently
with 10 or 50 mM of α-TP or α-T3 for 24 h. Medium were aspirated
and the cells were incubated with 5 mM JC-1 at 37 °C for 60 min.
Cells were then washed twice with PBS and 100 ml of PBS were
added into each well. Red ﬂuorescence (excitation 550 nm, emis-
sion 600 nm) and green ﬂuorescence (excitation 485 nm, emission
535 nm) were read using ﬂuorescence plate reader with multiple
reads per well (mrpw) setting. Ratios of red ﬂuorescence:green
ﬂuorescence were determined.
Caspase-3 activity assay
2.5104 TAMH cells were seeded into 96 well plate overnight.
2 mM APAP or 450 mM H2O2 were treated concurrently with 10 or
50 mM of α-TP or α-T3 for 24 h. The caspase 3/7 level was de-
termined with a Caspase-Glos 3/7 Reagent assay kit performed
according to the manufacturer’s protocol. The caspase 3/7 levels
were normalized against total cell number of their respective
groups.
Statistical analysis
Data were expressed as means7standard error of means (SEM)
and analyzed using one way ANOVA. Statistical signiﬁcance of
difference was accepted at the p-values of less than 0.05.
Results
Characterization of cytotoxicity and cellular uptake of tocotrienol (T3)
Fig. 1. Characterization of cytotoxicity and cellular uptake of vitamin E analogs.
(A) Experiments on the cytotoxicity of vitamin E analogs were performed in TAMH
hepatocytes. 5, 10, 25 mM of δ- and γ-T3 and 10, 50, 100 mM of α-TP and α-T3 were
added and MTT were performed 24 h later. Cell viability was normalized against
vehicle control group and expressed in percentage. n¼6 per group; *po0.05 ver-
sus control group. (B) Cellular uptake of α-TP, α-T3, δ-T3 and γ-T3 in TAMH hepa-
tocytes were performed. The cells were cultured in DMEM/F12 medium with each
analog at the indicated concentrations for 24 h and the cellular vitamin E analog
content was measured using an HPLC system. Mean values of cellular vitamin E
analog content are shown with standard error. n¼3 per group.
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Preliminary characterization of T3 analogs and α-TP in terms of
cytotoxicity and cellular uptake were performed in TAMH cells as a
starting point. Cytotoxicity assay as shown in Fig. 1A revealed that
α-TP and α-T3 were not toxic at up to a concentration of 100 mM
with the cell viability maintained above 80%. On the contrary,
signiﬁcant reduction in cell viability was observed in δ-T3 and γ-
T3 at concentration of 10 mM and above (po0.05). Apart from the
cytotoxicity characterization, we determined the cellular uptake of
Vitamin E analogs to account for uptake differences as a potential
confounding variable to the biological effectiveness of each analog
in the cells. δ-T3 held the highest uptake among the analogs across
all tested concentrations whereas the uptake of α-T3 and γ-T3
reach a plateau from 5 to 25 mM (Fig. 1B). The uptake of α-TP in-
creased slightly from 5 to 25 mM and remained unchanged at
higher concentration, while the other T3 analogs increased pro-
gressively over the range of treated concentrations. This dose de-
pendent study of cellular uptake of analogs revealed increased
level of uptake α-T3, γ-T3 and δ-T3 compared to that of α-TP after
incubation for 24 h across different concentrations.Effect of T3 analogs on APAP and H2O2-induced cell death in TAMH
cells
To evaluate T3 analogs responses towards different mechan-
isms of toxicity; two classical toxicants were used to induce toxi-
city: APAP represents liver injury model caused by both covalent
modiﬁcation of protein targets and oxidative stress mediated in-
jury pathways [25] while H2O2 represents exclusive oxidative
stress-induced liver injury pathway. Firstly, TAMH cultures were
exposed concomitantly to APAP or H2O2 in the presence or ab-
sence of α-T3/α-TP (10 and 50 mM) or δ-T3/γ-T3 (5 and 10 mM) for
24 h. In both toxicity models, α-TP and α-T3 demonstrated dose
dependent suppression of APAP- and H2O2-induced toxicity
(Fig. 2A and B). However, 10 mM of α-TP only demonstrated sig-
niﬁcant recovery in cell viability after oxidative stress injury but
not in APAP injury. Apart from that, lower concentration (5 mM)
but not higher concentration (10 mM) of γ-T3 was effective in in-
hibiting both toxicants induced injury. δ-T3 did not exhibit any
protection in the concurrent treatment study.
Secondly, pre-treatment experiment was performed by ﬁrst
incubating the analogs for 24 h followed by 24 h of APAP or H2O2
incubation. The pre-treatment model was set up to rule out the
possibility that α-TP or T3 analogs may react directly with H2O2 in
the medium before they were taken into the cells, thereby con-
founding the assessment whether any observed protective effects
arise from a cell-based mechanism. Based on the result shown in
Fig. 2C, only 50 mM of α-TP and α-T3 and 5 mM of δ-T3 preserved
signiﬁcant higher cell viability after APAP injury. On the other
hand, the effects of α-TP and α-T3 against H2O2 on cell viability
were found to be more signiﬁcant where the effective dose were
observed at 10 μM and above (Fig. 2D). In contrast to the con-
current treatment study, γ-T3 did not exhibit any inhibitory effect
against either toxicant in this pre-treatment study. Overall, the
cytoprotection against APAP- and H2O2-induced liver injury in
TAMH cells were consistent across α-TP and α-T3 while α-T3
showed the highest percentage recovery compared to the α-TP.
Effect of α-TP and α-T3 on GSH activity
Given the greater protection manifested by concurrent treat-
ment approach, subsequent experiments were performed using
this mode of treatment to achieve more observable and biologi-
cally signiﬁcant effects. To further investigate the underlying me-
chanisms of antioxidant α-T3 against APAP and H2O2 toxicity,
cellular GSH levels were determined. Fig. 3A and B demonstrates
signiﬁcant decreased in intracellular GSH after 24 h incubation of
APAP or H2O2. Results showed that the depletion of GSH by APAP
was not inhibited despite exposure to cytoprotective concentra-
tion of α-TP or α-T3 (Fig. 3A). However, 10 mM of α-TP and both
concentrations of α-T3 exhibited antioxidant activity against H2O2
injury, maintaining its intracellular GSH level and inducing higher
generation of GSH (Fig. 3B). Interestingly, higher dosage of α-TP
reversed the situation where no signiﬁcant higher level of in-
tracellular GSH was detected after the H2O2 injury.
Anti-oxidative effects of α-TP and α-T3 on intracellular ROS and an-
tioxidant genes activities
Subsequently, the intracellular ROS level and antioxidant genes
activities were measured to examine the antioxidant effects of α-
TP or α-T3. Firstly, the intracellular ROS level was determined by
ﬂuorescent probe CM-H2DCFDA and the results revealed that both
APAP and H2O2 induced death was preceded by a signiﬁcant in-
crease in intracellular ROS (Fig. 4A and B). Conversely, the rise in
ROS was suppressed by both α-TP and α-T3 in a dose-dependent
manner as compared to its basal level.
Fig. 2. Cytoprotective effect of vitamin E analogs in concurrent and pre-treatment of APAP- and H2O2-induced injury in TAMH hepatocytes. 5, 10 And 50 mM of respective
vitamin E analogs were added into respective concentration of APAP (A,C) and H2O2 (B,D) concurrently (A,B) and 24 h before treatment (C,D). MTT assays were performed
24 h later. Cell viability was normalized against vehicle control group and expressed in percentage. n¼6 per group; *po0.05 versus APAP or H2O2 at 0 mM treatment group.
Fig. 3. Effects of α-TP and α-T3 in GSH after APAP- and H2O2-induced injury in TAMH hepatocytes. 0, 10 and 50 mM of each analog were added into TAMH cells concurrently
with APAP (A) and H2O2 (B) and cellular GSH levels were performed 24 h later. n¼3 per group; #po0.05 versus control, *po0.05 versus APAP or H2O2 without analog
treatment.
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Fig. 4. Effect of α-TP and α-T3 in intracellular ROS and antioxidant gene activity after APAP- and H2O2-induced injury in TAMH hepatocytes. 0, 10 And 50 mM of each analog
were added into TAMH cells concurrently with APAP (A) and H2O2 (B) and intracellular ROS levels were performed 24 h later and normalized against each group’s total
number of viable cells. n¼3 per group; #po0.05 versus control, *po0.05 versus APAP or H2O2 without analog treatment. (C) Expression of Nrf-2 and HO-1 were determined
by immunoblotting after 24 h concurrent treatment of (þ) 10 mM and (þþ) 50 mM of α-TP/α-T3 in APAP- or H2O2-injury models. Blot shown here was representative from a
number of experiments, n¼3. Densitometric analysis was performed by normalizing the intensity of the Nrf-2 and HO-1 bands to respective actin controls in the same
samples and displayed as a bar graph for (D) APAP and (E) H2O2 injury model.
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α-T3 against the oxidative stress, the protein expressions of anti-
oxidant response genes HO-1 and Nrf-2 were carried out in an
immunoblot assay. In the APAP model, both HO-1 and Nrf-2 pro-
teins were downregulated and these expressions were not affected
by the treatment of any protective concentrations of α-TP/α-T3
(Fig. 4C and D). On the other hand, H2O2 induced Nrf-2 expression
while paradoxically reduced HO-1 expression. The 50 mM of α-TPtriggered similar amount of Nrf-2 expression as compared to 10 or
50 mM of α-T3, and were signiﬁcantly higher than H2O2 control
(Fig. 4C and E). Even though 50 mM of α-TP induced Nrf-2 ex-
pression, HO-1 expression remained unchanged compared to the
H2O2 control. On the contrary, HO-1 expression was highly in-
duced following the increased in Nrf-2 expression after the
treatment of α-T3.
Fig. 5. Effect of α-TP and α-T3 in LPO formation and mitochondrial MPT after APAP- and H2O2-induced injury in TAMH hepatocytes. 0, 10 And 50 mM of each analog were
added into TAMH cells concurrently with APAP (A,C) and H2O2 (B,D) and 24 h later the intracellular LPO levels were measured using TBARS assay (A and B) while the MPT
levels were detected using JC-1 probe (C and D). The MPT levels were expressed in the red to green ﬂuorescence ratio. n¼3 per group; #po0.05 versus control, *po0.05
versus APAP or H2O2 without analog treatment.
C.Y. Tan et al. / Redox Biology 4 (2015) 308–320314Effects of α-TP and α-T3 on lipid peroxidation (LPO) and mitochon-
drial depolarization
Typically, overproduction of ROS mediates oxidative damagemanifested by LPO, proteins oxidation and carbonylation, and DNA
alterations, which in turn disrupt cellular function and integrity. To
examine the involvement of α-TP and α-T3 in LPO, the levels of
MDA formation was quantiﬁed. The release of MDA doubled after
Fig. 6. Effect of α-TP and α-T3 in Bcl-xL anti-apoptotic gene and on caspase 3 activity after APAP- and H2O2-induced injury in TAMH hepatocytes. (A) Expression of Bcl-xL was
determined by immunoblotting after 24 h concurrent treatment of 10 and 50 mM of α-TP/α-T3 in APAP- or H2O2-injury model. Blot shown here was representative from a
number of experiments, n¼3. Densitometric analysis was performed by normalizing the intensity of Bcl-xL to respective actin controls in the same samples and displayed as
a bar graph for (B) APAP and (C) H2O2 injury model. Caspase 3/7 was measured after 24 h treatment of 10 and 50 mM of α-TP/α-T3 in (D) APAP- or (E) H2O2-injury. n¼3 per
group; #po0.05 versus control, *po0.05 versus APAP or H2O2 without analog treatment.
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(Fig. 5A and B). In the APAP injury model, only 50 mM of α-T3
managed to suppress the formation of LPO signiﬁcantly (Fig. 5A).
However, both α-TP and α-T3 prevented the H2O2 induced LPO
where α-T3 appeared to be more effective (Fig. 5B).
To evaluate the mitochondria depolarization due to excessive
ROS, JC-1 ﬂuorescent probe was used where red ﬂuorescent
(emission at 590 nm) indicates healthy cells while green ﬂuor-
escent (emission at 525 nm) indicates apoptotic cells. From Fig. 5C,treatment of APAP caused a decrease in red/green ﬂuorescence
intensity but the addition of α-TP inhibited the mitochondrial
depolarization, resulting in a similar level to the control. Even
though α-T3 also reversed the mitochondrial depolarization
caused by APAP, the protective effect was not as great as α-TP. On
the other hand, both α-TP and α-T3 demonstrated a similar extent
of inhibition in a dose dependent manner against the H2O2 in-
duced reduction in mitochondrial potential (Fig. 5D).
Fig. 7. Effects of α-TP and α-T3 on qRT-PCR analysis of iNOS, TNF α, and IL-6
inﬂammatory expression. Liver inﬂammatory responses in TAMH cells treated with
or without 10 and 50 mM of α-TP/α-T3 concurrently in (A) APAP or (B) H2O2, for
24 h. All the expression were normalized against GAPDH expression of the same
sample and presented as fold-increase over the controls. #po0.05 versus control,
*po0.05 versus APAP or H2O2 without analog treatment.
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To explore the anti-apoptotic effects of these analogs, Bcl-xL
expression, a mitochondrial anti-apoptotic protein predominant in
hepatocytes, and caspase 3 activities were measured. From Fig. 6A,
the expression of Bcl-xL was at a very low level after the treatment
of APAP and H2O2 compared to the control. Additional treatment
of α-TP or α-T3 did not result in higher expression of Bcl-xL in
APAP model (Fig. 6B). On the other hand, 50 mM of α-TP demon-
strated signiﬁcantly higher expression of Bcl-xL in contrast to the
H2O2 control. Likewise, both concentrations of α-T3 showed si-
milar extent of Bcl-xL induction, with two-fold elevation as com-
pared to 50 mM α-TP in the H2O2 model (Fig. 6C).
On the other hand, caspase 3 activity was highly induced after
the treatment of APAP and H2O2. Both α-TP and α-T3 analogs
salvaged the injured cells by reducing the total caspase 3 activity
in APAP model (Fig. 6D). Although 10 mM of α-TP did not sig-
niﬁcantly inhibit caspase 3 activity in the H2O2 model, 50 mM of α-
TP as well as both α-T3 concentrations lowered the total caspase
3 activity to half of the activity detected in the H2O2 model
(Fig. 6E).
Effects of α-TP and α-T3 on gene regulation in ROS induced
inﬂammation
Tissue inﬂammation is frequently activated as a secondary re-
sponse when cells undergo injury. Hence, by exploring the effect of
α-TP/α-T3 on pro- and anti-inﬂammatory protein expressions, it is
possible to determine the exact stage of the injury-recovery re-
sponse paradigm where α-TP and α-T3 are involved in. In our
injury model, hepatic regeneration markers such as pMet, PCNA,
NF-kB and inﬂammatory cytokines like TNF-α, IL-6 and iNOS were
induced upon liver injury. With the treatment of α-TP and α-T3,
the expressions of TNF-α, IL-6 and iNOS were downregulated
compared to the expression levels in APAP or H2O2 injury controls
(Fig. 7A and B). 50 mM of α-T3 demonstrated lowest expressions
among the tested analogs and concentrations across all the mea-
sured inﬂammatory responses. These results support that the
protective effect of α-TP/α-T3 responded before the injury sets in,
hence serving as preventive agents against APAP and H2O2 injury.
Effects of α-TP and α-T3 on protein expressions in liver regeneration
The role of liver regeneration as a complementary healing re-
sponse to ROS prevention was considered in our model. To ex-
amine the regeneration effect, a subset of key liver regeneration
markers, pMet, NF-kB and PCNA were monitored by immunoblot
assay. As detailed in Fig. 8A and B, there were no signiﬁcant dif-
ference across pMet, NF-kB or PCNA in the APAP injury model but
the expressions were highly induced in a dose dependent manner
for α-TP and α-T3 treatments in H2O2 injury model (Fig. 8A and C).
The expressions of these proteins in α-T3 treatment were found to
be higher than the α-TP treatment (Fig. 8A).Discussion
This work set out to ﬁrst evaluate analog-speciﬁc effects of
Vitamin E in attenuating xenobiotic-induced liver injury, followed
by assessing the underlying mechanisms of the cytoprotection. As
such, we explored each analog’s hepatoprotective potential in
well-deﬁned models of toxicity APAP and H2O2 administered to
metabolically competent TAMH cells. Cytotoxicity of different T3
analogs were ﬁrst explored in the cell viability followed by the
cellular uptake assay and the effects were compared in parallelwith α-TP. Accordingly, our experiments have demonstrated that
α-T3 is the analog that consistently preserved the highest cell
viability after the injury of APAP and H2O2 while γ-T3 and δ-T3
produced marginal and inconsistent protective effect. Notably, α-
T3 exerted both preventive and protective effect against DILI. It
acts as an antioxidant by reacting with ROS, protecting the cells
from injury while inducing the remnant hepatocytes regeneration.
The powerful antioxidant properties of α-T3 can be proven by its
effectiveness against the H2O2-injury model compared to the APAP
model. We qualiﬁed the antioxidant potential of α-T3 by ﬁrstly
investigating the relative hepatoprotection capacities of each
analog and the underlying mechanisms by which analog exerts its
cytoprotection action.
The cytoprotective effect of α-T3 was found to be more potent
compared to α-TP in both injury models. As claimed by Packer
et al., the effectiveness of different Vitamin E analogs may involve
two main features, i.e., the substituent on the chromanol nucleus
“head” and the properties of the side chain “tail” [26]”. Based on
the differences in the tail structure, it has been suggested that the
unsaturated side chain of α-T3 contributes to the stronger dis-
ordering of membrane lipids which makes interaction of chro-
manols with lipid radicals more efﬁcient and therefore, compared
to α-TP, α-T3 distributed more uniformly within the membrane
bilayer and thus possessed higher antioxidant efﬁcacy against
oxidative damage directed at lipid membranes [19]. Studies also
indicated that α-T3 which is located nearer to the membrane
surface may contribute to greater recycling efﬁciency of the
Fig. 8. Effects of α-TP and α-T3 on liver regeneration markers after APAP- or H2O2-induced injury in TAMH hepatocytes. (A) Expressions of pMet, NF-κB and PCNA were
determined by immunoblotting after 24 h concurrent treatment of 10 and 50 mM of α-TP/α-T3 in APAP- or H2O2-injury models. Blot shown here was representative from a
number of experiments, n¼3. Densitometric analysis was performed by normalizing the intensity of pMet, NF-κB and PCNA to respective actin controls in the same samples
and displayed as a bar graph for (B) APAP and (C) H2O2 injury model.
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hibition of LPO [27]. However, these studies were performed in
ex vivo model and thus the antioxidant efﬁcacy might differ in
contrast with in vitro or in vivo studies.
Barring any difference in free radical scavenging potential, the
better protection shown by α-T3 could be attributable to higher
cellular uptake rate or accumulation of α-T3 in the cells, a possi-
bility reported in previous studies [28,29]. Although γ-T3 has been
shown to be more potent in other cases, the issue of uptake as a
confounding effect remains elusive. In this study, similar cell via-
bility was observed after the treatment of 50 mM α-TP in APAP and
H2O2 for concurrent and pre-treatment study. One of the possible
explanations to this could be due to the saturable uptake of α-TP at
these higher concentrations, leading to similar amount of α-TP
achieved in the cells for protective effect. Nevertheless, the cellular
uptake shown in this study were in accordance with the reported
ﬁndings where α-T3 has higher cellular uptake than α-TP in Jurkat
cells [28] and primary cortical neurons [29]. The higher uptake of
α-T3 could be due to the unsaturated side chain which allows
them to be incorporated into the cell membrane more easily thanα-TP [30]. By comparing at similar intracellular concentration at-
tained, some reported identical cytoprotection and resistance ef-
fect against oxidative stress of α-T3 and α-TP [29,31,32]. Although
the intracellular concentration remained a confounding factor in
this study, it may be noteworthy that apart from the different
cytoprotective effects of α-T3 and α-TP observed in this study
could also be attributed to the difference in antioxidant potency or
non-antioxidant function of each analog.
In the liver, APAP is metabolized by P450 into a reactive metabolite,
NAPQI. CYP3E1 and CYP3A4 are important enzymes of the CYPP450
system responsible for this metabolism reaction. It has been reported
that all the T3 but not TP analogs induced 3–5 fold of CYP3A4 ex-
pression in the primary hepatocytes [33]. α-T3 has also been reported
to stimulate the upregulation of endogenous CYP3A4 and CYP3A5
more signiﬁcantly than α-TP [34]. As a result, these enzymes will
cause higher generation of NAPQI from APAP, signifying more injuries
in the response to α-T3 exposure. Nevertheless, similar protective ef-
fects were observed after the treatment of α-T3 and α-TP. Therefore,
these results may indicate higher anti-oxidant potency of α-T3 in
preventing against the oxidative stress compared to α-TP.
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effect against GSH level followed by the ROS generation and its
adverse effects were examined. It has been claimed that the re-
generation of bioactive Vitamin E from its oxidized state is a GSH-
dependent process [35]. Other clinical studies reported that the
pharmacological doses of Vitamin E enhance red blood cell levels
of reduced glutathione [36] and plasma GSH/GSSG ratio in humans
[37,38]. Parallel with these ﬁndings, the result in this study
showed that the GSH level in H2O2 remained signiﬁcantly higher
after the treatment of both α-TP and α-T3 compared to the control,
but not in the case of APAP. A plausible explanation for this effect
could be that the GSH oxidation under the inﬂuence of H2O2 could
have been restored by α-TP/α-T3 thus maintaining its high GSH
level, whereas GSH committed to conjugation with electrophilic
NAPQI in APAP model may not be readily restored by the same
treatment.
Given the dichotomous role of GSH in oxidative stress and
protein binding, a targeted investigation into ROS was performed.
Despite the different outcome in GSH level, both α-TP and α-T3
were able to inhibit the elevation of intracellular ROS in both APAP
and H2O2 injury models. It has been reported in a glutamate-in-
duced neurotoxicity study that even though α-TP/α-T3 did not
inhibit the decrease in GSH level, ROS level was signiﬁcantly
suppressed at the respective neuroprotection concentrations [29].
Similarly, α-T3 was reported to have no effect in sparing the glu-
tamate-induced depletion of intracellular GSH but it completely
prevented the accumulation of intracellular peroxides even if the
α-T3 was treated 5 h after the glutamate treatment [39]. Collec-
tively, the ﬁndings of these studies where prevention of ROS re-
lease and mitochondrial stress were manifested despite an initial
GSH depletion might indicate that α-TP and α-T3 were acting on
different levels of the cytoprotection cascade. In another words,
apart from preventive measure of blocking the chemical insult
caused by ROS, α-TP and α-T3 were also able to exert their func-
tion during injury and post-injury.
Based on the study of Khanna et al., α-T3 was able to prevent
the loss of mitochondrial membrane potential arising from
homocysteic acid and linoleic acid [40]. Moreover, α-T3 has been
reported to exert more pronounced inhibitory effects on LPO in rat
liver and murine microsomes [19,41] and have higher potency in
scavenging the very reactive HO  and lipid peroxyl radical
(ROO●) in liposomes than α-TP [27]. In line with these studies, our
ﬁndings demonstrated suppression of LPO and MPT formation by
both α-T3 and α-TP, given that the α-T3 exhibits stronger anti-
oxidant effect than α-TP. We are cognizant that TBARS assay for
LPO quantiﬁcation can be confounded by reaction of the thio-
barbituric substrate with numerous complex substances especially
in vivo system. Nevertheless, in this study, TBARS assay was solely
performed on in vitro liver cell line where any interfering sub-
stances were minimal. Effect if any, was exerted uniformly across
the various experimental arms. Therefore, the results indirectly
reﬂected the lipid peroxidation activity and were reliable in
comparison with the negative control.
Other than the antioxidant function, α-T3 was found to possess
anti-apoptotic activity through inducing the Bcl-xL anti-apoptotic
protein while blocking the caspase 3 activity in H2O2 model.
However, this was not apparent in the APAP injury model. This
difference could be due to the differential injury pathway elicited
by each toxicant. Aside from inducing oxidative stress pathway,
APAP also induces the mitochondria independent pathway, po-
tentially through the induction of TNF-α and the activation of the
extrinsic apoptotic cascade. This explains the ﬁndings where α-TP/
α-T3 having minimal effect in Bcl-xL induction while demon-
strating signiﬁcant suppression of caspase 3 (the convergent point
of the extrinsic and intrinsic apoptotic pathway) activity in
APAP model. It is worth noting that from our ﬁndings, both α-TPand α-T3 are involved in the inhibition of mitochondria dependent
and independent apoptosis process.
Overproduction of ROS is often associated with inﬂammation,
which also plays an important and multiplier role in toxicant-in-
duced acute liver injury. Following the exposure to hepatotoxic
chemicals, the generated oxidative stress can trigger inﬂammatory
cytokine responses in injured hepatocytes and Kupffer cells [42].
The release of cytokines activates a slew of inﬂammatory re-
sponses that orchestrate the removal of dead or dying cells, where
it is essential for regeneration of lost tissue. Here, TNF-α and IL-6
were found to be highly induced after the exposure to APAP or
CCl4 as toxicants [43,44]. Similarly, the elevated TNF-α, IL-6 and
iNOS genes in this study were downregulated after the treatment
of α-TP/α-T3. Even though a monoculture system employed here
prevented us to see the complete effect of inﬂammation, the
perturbation of many markers that pointed towards anti-in-
ﬂammation indicates that α-TP/α-T3 attenuated toxicant-induced
liver injury. It is therefore considered that the protective effect of
α-TP/α-T3 against the APAP and H2O2-induced injury took place at
the ROS preventive or early injury stage.
Finally, the induction of oxidative stress can also lead to im-
pairment in liver regeneration. Recently, Nrf-2 has been shown to
play a critical role in liver regeneration where Nrf-2-deﬁcient mice
demonstrated signiﬁcant delay after partial hepatectomy [45]. Nrf-
2 is known to regulate the cellular antioxidant defense system,
thus reduction in Nrf-2 and its target antioxidant gene expression
will result in enhanced oxidative stress. Apart from that, deﬁciency
in Nrf-2 which demonstrated the increased susceptibility of the
mice to APAP also suggests the important role of Nrf-2 in the
regulation of GSH synthesis and cellular detoxiﬁcation processes
[46,47]. HO-1 is an Nrf-2-targeted gene and the induction of HO-1
in acute and chronic hepatic inﬂammation rodent models resulted
in improvement of liver damage and downregulation of proin-
ﬂammatory cytokines [48]. As shown in this study, α-T3 possessed
a stronger effect than α-TP and was more effective in inducing the
suppressed endogenous antioxidative defense mechanisms of Nrf-
2 and HO-1 against the H2O2 oxidative stress injury. At the same
time, a signiﬁcant trend of elevation in the regeneration markers
of pMet, NF-kB and PCNA were observed. Nonetheless, the nega-
tive effect of α-TP/α-T3 in the Nrf-2 and HO-1 expression in APAP
injury resulted in no difference in the regeneration markers. These
ﬁndings are in agreement with the previous studies shown where
Nrf-2 is crucial in inducing liver regeneration through regulating
the antioxidative enzymes during injury.Conclusion
In conclusion, α-TP/α-T3 demonstrated dose-dependent pro-
tective effects against APAP and H2O2-induced liver injury by ar-
resting free radicals, blocking mitochondria stress, inhibiting oxi-
dative stress and triggering endogenous anti-oxidative stress.
These biochemical effects also triggered signals suggestive of anti-
inﬂammatory responses and hepatocyte regeneration upon injury
(Fig. 9). Overall, these molecular events staged at different time
points of the injury process complements each other to achieve a
more effective protective response. Finally, α-T3 seems to be a
more potent hepatoprotective analog among the tocotrienols and
α-TP at the same dosage in vitro, likely owing to its higher in-
corporation into the cells. Nevertheless, the potency at similar
intracellular contents deserved a future investigation. Taken as a
whole, both α-TP and α-T3 analogs demonstrated distinct and
differential protective effect against oxidative stress in H2O2
compared to APAP model. Isoform-speciﬁc therapeutic advantages
among Vitamin E could be more carefully investigated and
exploited for future use.
Fig. 9. Proposed α-T3 protection pathways in APAP- and H2O2-induced liver injury in TAMH cells.
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